以罗非鱼副产物为原料,采用酸性蛋白酶进行酶解制备抗菌肽,以期提高罗非鱼副产物的利用率和附加值。以对无乳链球菌抑菌效果为指标,通过单因素及正交试验获得最佳酶解工艺条件。测定酶解产物的最小抑菌浓度(minimum inhibit concentration,MIC)以评价其抑菌效果,并采用高效体积排阻色谱(high-performance size-exclusion chromatography,HPSEC)法分离酶解产物,获得肽段分子质量分布图。通过对冻干粉蛋白氨基酸组成分析,探索氨基酸组成与抑菌活性的关系及其作为水产动物饲料添加成分的可行性。结果表明,最佳酶解条件为：酶解时间5 h,酶解温度40 ℃,pH 2.0,料液比1∶5 (g∶mL),酶添加量为0.7%,对无乳链球菌的抑菌圈直径为23.38 mm,MIC达到12.5 μg/μL,说明可以通过酶解方法得到对无乳链球菌具有较好抑菌效果的抗菌肽产品。经最优条件酶解后的罗非鱼副产物粗肽分子质量有68.08%分布在3 000 Da以下。氨基酸分析表明,酶解物中与抑菌活性相关的氨基酸含量较高并具有均衡的氨基酸组成,初步表明罗非鱼副产物酶解肽具有较强的营养和功能潜力,为罗非鱼副产物的高值化利用提供了新途径。
岑剑伟
,
赵敏
,
杨贤庆
,
李来好
,
黄卉
,
赵永强
,
魏涯
,
杨少玲
,
林织
. 罗非鱼副产物抗菌肽的制备及其对无乳链球菌抑菌活性分析[J]. 食品与发酵工业, 2020
, 46(15)
: 39
-45
.
DOI: 10.13995/j.cnki.11-1802/ts.023832
In order to expand the usages of tilapia by-products,acid protease was adopted to hydrolyze tilapia by-products to prepare antibacterial peptides. The optimum conditions of enzymatic hydrolysis were obtained by single factor and orthogonal experiments by the index of the antibacterial effect to Streptococcus agalactiae. The minimum inhibitory concentration (MIC) of the enzymatic hydrolysate was tested to confirm its effectiveness,and the hydrolysate was separated by high-performance size-exclusion chromatography (HPSEC) to show its molecular weight distribution. The amino acid composition of the enzymatic hydrolysate was assayed to explore the relationship between composition and antibacterial activity and its feasibility as an additional component to aquatic animal feed. The results showed that the optimum conditions of enzymatic hydrolysis were 40 ℃,hydrolyzing for 5 h with the enzyme dosage of 0.7%,pH 2.0,and solid-liquid ratio of 1∶5 (g∶mL). The diameter of the inhibition zone against Streptococcus agalactiae was 23.38 mm. The MIC value against S. agalactiae was 12.5 μg/μL. Under optimal conditions,the molecular weight of the crude peptides of tilapia by-products was 68.08% distributed below 3 000 Da. The preliminary results indicate that the hydrolysates of tilapia by-products have strong nutritional and functional potential,which provides a new pathway for the high-value utilization of tilapia by-products.
[1] TANG S S,PRODHAN Z H,BISWAS S K,et al.Antimicrobial peptides from different plant sources: Isolation,characterisation,and purification[J].Phytochemistry,2018,154:94-105.
[2] RAJANBABU V,CHEN J Y.Applications of antimicrobial peptides from fish and perspectives for the future[J].Peptides,2011,32(2):415-420.
[3] JOHANNES K,DAVID J C.The vast structural diversity of antimicrobial peptides[J].Trends in Pharmacological Sciences,2019,40(7):517-528.
[4] SALAS C E,BADILLO-CORONA J A,RAMREZ-SOTELO G,et al.Biologically active and antimicrobial peptides from plants[J].BioMed Research International,2015,2 015(1):1-11.
[5] ZHANG D F,GAO Y X,LI Q Y,et al.An effective live attenuated vaccine against Streptococcus agalactiae infection in farmed Nile tilapia (Oreochromis niloticus)[J].Fish and Shellfish Immunology,2020,98:853-859.
[6] ROSLAN J,MD.YUNOS K F,ABDULLAH N,et al.Characterization of fish protein hydrolysate from tilapia(Oreochromis niloticus) by-product[J].Agriculture and Agricultural Science Procedia,2014,2:312-319.
[7] SRICHANUN M,TANTIKITTI C,KORTNER T M,et al.Effects of different protein hydrolysate products and levels on growth,survival rate and digestive capacity in Asian seabass (Lates calcarifer Bloch) larvae[J].Aquaculture,2014,428/429:195-202.
[8] DOAN H V,HOSEINIFAR S H,SRINGARM K,et al.Effects of Assam tea extract on growth,skin mucus,serum immunity and disease resistance of Nile tilapia (Oreochromis niloticus) against Streptococcus agalactiae[J].Fish and Shellfish Immunology,2019,93:428-435.
[9] ZHANG Z,YU A G,LAN J F,et al.GapA,a potential vaccine candidate antigen against Streptococcus agalactiae in Nile tilapia (Oreochromis niloticus)[J].Fish and Shellfish Immunology,2017,63:255-260.
[10] ZHU J J,GAN X,AO Q W,et al.Basal polarization of the immune responses to Streptococcus agalactiae susceptible and resistant tilapia (Oreochromis niloticus)[J].Fish and Shellfish Immunology,2018,75:336-345.
[11] ROBERT M,ZATYLNY-GAUDIN C,FOURNIER V,et al.Molecular characterization of peptide fractions of a tilapia(Oreochromis niloticus) by-product hydrolysate and in vitro evaluation of antibacterial activity[J].Process Biochemistry,2015,50(3):487-492.
[12] 吴林泽,李从发.罗非鱼下脚料酶解产物中抗菌肽的初步研究[J].科技信息(科学教研),2007(17):283;428.
[13] 杨莉莉. 鱼鳞胶原肽的分步酶解法制备及其特性研究[D].武汉:华中农业大学,2011.
[14] GB/T 5009.5—2016食品中蛋白质的测定[S].北京:中国标准出版社,2016.
[15] BERNARDINI R D,HARNEDY P,BOLTON D,et al.Antioxidant and antimicrobial peptidic hydrolysates from muscle protein sources and by-products[J].Food Chemistry,2011,124(4):1 296-1 307.
[16] 李朝,柯常亮,古小莉,等.麻醉剂丁香酚对鳗弧菌抑菌效果初步研究[J].南方水产科学,2019,15(2):58-63.
[17] 杨大俏. 近江牡蛎多糖多肽联产制备工艺、结构鉴定及活性评价[D].上海:上海海洋大学,2019.
[18] GB/T 5009.124—2016食品中氨基酸的测定[S].北京:中国标准出版社,2016.
[19] GB/T 18246—2019饲料中氨基酸的测定[S]B/T 18246—2019饲料中氨基酸的测定[S].北京:中国标准出版社,2019.
[20] 施永清,王巧巧,吴丹丽,等.响应面试验优化双酶酶解法制备鱼鳞抗菌肽工艺及其抑菌性能分析[J].食品科学,2018,39(6):155-161.
[21] 王焙,张登科,史咏梅,等.鲣鱼暗色肉抗菌肽的制备及分离纯化[J].食品与发酵工业,2019,45(19):104-111.
[22] 顾晨涛,黄洒,王雪燕,等.鲫鱼鱼鳞抗菌多肽的制备纯化及其抑菌活性[J].食品科学,2019,40(22):193-198.
[23] 李露园,王升帆,朱有贵,等.酶法制备鲟鱼皮胶原蛋白多肽及其抗氧化活性研究[J].食品与发酵工业,2019,45(20):138-143.
[24] 张永刚,栾林林,任海,等.中草药对大菱鲆源哈维氏弧菌的体外抑菌效果[J].淡水渔业,2018,48(3):78-82.
[25] DING J,LIANG R,YANG Y Y,et al.Optimization of pea protein hydrolysate preparation and purification of antioxidant peptides based on an in silico analytical approach[J].LWT-Food Science and Technology,2020,123:109 126.
[26] RON$\check{C}$EVI$\acute{C}$ T, $\check{C}$IKEŠ-$\check{C}$ULI$\acute{C}$ V,MARAVI$\acute{C}$ A,et al.Identification and functional characterization of the astacidin family of proline-rich host defence peptides (PcAst) from the red swamp crayfish (Procambarus clarkii,Girard 1852)[J].Developmental and Comparative Immunology,2020,105:103 574.
